Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.

Authors

Christine M Durand
Adam A Capoferri
Andrew D Redd
Marianna Zahurak
Daniel I S Rosenbloom
Ayla Cash
Robin K Avery
Javier Bolaños-Meade
Catherine M. Bollard, George Washington University
C Korin Bullen
Charles Flexner
Ephraim J Fuchs
Joel Gallant
Doug E Gladstone
Christopher D Gocke
Richard J Jones
Yvette L Kasamon
Jun Lai
Mark Levis
Leo Luznik
Kieren A Marr
Holly L McHugh
Seema Mehta Steinke
Paul Pham
Christopher Pohlmeyer
Keith Pratz
Shmuel Shoham
Nina Wagner-Johnston
Daniel Xu
Janet D Siliciano
Thomas C Quinn
Robert F Siliciano
Richard F Ambinder

Document Type

Journal Article

Publication Date

7-7-2020

Journal

Lancet HIV

DOI

10.1016/S2352-3018(20)30073-4

Comments

Online ahead of print

APA Citation

Durand, C., Capoferri, A., Redd, A., Zahurak, M., Rosenbloom, D., Cash, A., Avery, R., Bolaños-Meade, J., Bollard, C. M., Bullen, C., Flexner, C., Fuchs, E., Gallant, J., Gladstone, D., Gocke, C., Jones, R., Kasamon, Y., Lai, J., Levis, M., Luznik, L., Marr, K., McHugh, H., Mehta Steinke, S., Pham, P., Pohlmeyer, C., Pratz, K., Shoham, S., Wagner-Johnston, N., Xu, D., Siliciano, J., Quinn, T., Siliciano, R., & Ambinder, R. (2020). Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.. Lancet HIV, (). http://dx.doi.org/10.1016/S2352-3018(20)30073-4

Peer Reviewed

1